ExLibris header image
SFX Logo
Title: Human hepatitis B vaccine from recombinant yeast
Source:

Nature [0028-0836] McAleer, William yr:1984


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Assad, S. "Over a decade of experience with a yeast recombinant hepatitis B vaccine." Vaccine 18.1-2 (1999): 57-67. Link to Full Text for this item Link to SFX for this item
2. Lavanchy, D. "Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures." Journal of viral hepatitis 11.2 (2004): 97-107. Link to Full Text for this item Link to SFX for this item
3. Black, S. "Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children." The Pediatric infectious disease journal 19.3 (2000): 187-195. Link to SFX for this item
4. Yap, I. "Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity." Vaccine 10.7 (1992): 439-42. Link to Full Text for this item Link to SFX for this item
5. MINGIOLI, E S S. "Mutants of Escherichia coli requiring methionine or vitamin B12." Journal of bacteriology 60.1 (1950): 17-28. Link to Full Text for this item Link to SFX for this item
6. Mäkelä, P H H. "Efficacy of a pneumococcal conjugate vaccine against acute otitis media." The New England journal of medicine 344.6 (2001): 403-9. Link to SFX for this item
7. Custer, B. "Global epidemiology of hepatitis B virus." Journal of clinical gastroenterology 38.10 Suppl (2004): -68. Link to SFX for this item
8. Kogan, G. "Antioxidant properties of yeast (1 -> 3)-beta-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis." Carbohydrate polymers 61.1 (2005): 18-28. Link to SFX for this item
9. Shinefield, H. "Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants." The Pediatric infectious disease journal 21.3 (2002): 182-186. Link to SFX for this item
10. Pramoolsinsup, C. "Management of viral hepatitis B." Journal of gastroenterology and hepatology 17.SUPPL. 1: -45. Link to SFX for this item
11. Shepard, Beth P W. "Hepatitis B Virus Infection: Epidemiology and Vaccination." Epidemiologic reviews 28.2006 (2006): 112-25. Link to SFX for this item
12. Kao, Jia-Horng H. "Global control of hepatitis B virus infection." The Lancet infectious diseases 2.7 (2002): 395-403. Link to SFX for this item
13. Keating, Gillian M. "Recombinant Hepatitis B Vaccine (Engerix-B??)." Drugs 63.10 (2003): 1021-1051. Link to SFX for this item
14. Venters, C. "Recombivax-HB: perspectives past, present and future." Expert review of vaccines 3.2 (2004): 119-29. Link to SFX for this item
15. "Engerix B vaccine approved." AIDS patient care and STDs 12.11 (1998): 874-5. Link to SFX for this item
16. Yamaguchi, M. "Fine structure of hepatitis B virus surface antigen produced by recombinant yeast: comparison with HBsAg of human origin." FEMS microbiology letters 165.2 (1998): 363-367. Link to SFX for this item
17. Merican, I. "Asian-Pacific consensus statement on the management of chronic hepatitis B: an update." Journal of gastroenterology and hepatology 18.3 (2003): 239-45. Link to Full Text for this item Link to SFX for this item
18. Perna, N T T. "Genome sequence of enterohaemorrhagic Escherichia coli O157:H7." Nature 409.6819 (2000): 529-33. Link to Full Text for this item Link to SFX for this item
19. Shouval, D. "Improved Immunogenicity in mice of a mammalian cell-derived recombimant hepatitis 38 vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast derived vaccines." Vaccine 12.15 (1994): 1453-1459. Link to Full Text for this item Link to SFX for this item
20. Cutts, F T T. "Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial." The lancet 365.9465 (2005): 1139-1146. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced